NASDAQ:FTRE Fortrea (FTRE) Stock Price, News & Analysis $22.03 +0.62 (+2.90%) (As of 08/23/2024 ET) Add Compare Share Share Today's Range$21.30▼$22.4350-Day Range$20.04▼$27.9252-Week Range$18.07▼$41.02Volume809,055 shsAverage Volume1.20 million shsMarket Capitalization$1.97 billionP/E RatioN/ADividend YieldN/APrice Target$27.20 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Fortrea alerts: Email Address Fortrea MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside23.5% Upside$27.20 Price TargetShort InterestHealthy9.14% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.28Based on 5 Articles This WeekInsider TradingAcquiring Shares$298,700 Bought Last QuarterProj. Earnings Growth130.56%From $0.72 to $1.66 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.72 out of 5 starsMedical Sector407th out of 923 stocksMedical Laboratories Industry14th out of 18 stocks 3.2 Analyst's Opinion Consensus RatingFortrea has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 3 buy ratings, 7 hold ratings, and 1 sell rating.Amount of Analyst CoverageFortrea has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Fortrea's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted9.14% of the float of Fortrea has been sold short.Short Interest Ratio / Days to CoverFortrea has a short interest ratio ("days to cover") of 5.4.Change versus previous monthShort interest in Fortrea has recently decreased by 7.91%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldFortrea does not currently pay a dividend.Dividend GrowthFortrea does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for FTRE. Previous Next 2.1 News and Social Media Coverage News SentimentFortrea has a news sentiment score of -0.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Fortrea this week, compared to 4 articles on an average week.Search Interest5 people have searched for FTRE on MarketBeat in the last 30 days. MarketBeat Follows3 people have added Fortrea to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Fortrea insiders have bought more of their company's stock than they have sold. Specifically, they have bought $298,700.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 0.12% of the stock of Fortrea is held by insiders.Read more about Fortrea's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Fortrea are expected to grow by 130.56% in the coming year, from $0.72 to $1.66 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Fortrea is -15.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Fortrea is -15.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioFortrea has a PEG Ratio of 2.88. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioFortrea has a P/B Ratio of 1.13. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Fortrea's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaThis Crypto Is Set to Explode in AugustWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make HUGE gains. Industry Giants are Investing Heavily in Blockchain Technology and THIS COIN is at the Heart of Their Strategy. It's a groundbreaking opportunity that could be poised for extraordinary gains. Go here to get full details on this crypto now. About Fortrea Stock (NASDAQ:FTRE)Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.Read More FTRE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FTRE Stock News HeadlinesAugust 20, 2024 | americanbankingnews.comFortrea (NASDAQ:FTRE) PT Lowered to $23.00 at Deutsche Bank AktiengesellschaftAugust 18, 2024 | finance.yahoo.comFortrea Holdings Second Quarter 2024 Earnings: Misses ExpectationsAugust 24, 2024 | Darwin (Ad)Top Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.August 17, 2024 | finance.yahoo.comInsider Stock Buying Reaches US$1.08m On Fortrea HoldingsAugust 17, 2024 | americanbankingnews.comFortrea Holdings Inc. (NASDAQ:FTRE) Receives Consensus Rating of "Hold" from AnalystsAugust 16, 2024 | americanbankingnews.comFY2024 EPS Estimates for Fortrea Holdings Inc. (NASDAQ:FTRE) Lowered by William BlairAugust 15, 2024 | americanbankingnews.comFortrea (NASDAQ:FTRE) Issues Quarterly Earnings ResultsAugust 15, 2024 | americanbankingnews.comBank of America Lowers Fortrea (NASDAQ:FTRE) Price Target to $21.00August 24, 2024 | Darwin (Ad)Top Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.August 15, 2024 | americanbankingnews.comFortrea Holdings Inc. Forecasted to Earn Q3 2024 Earnings of $0.26 Per Share (NASDAQ:FTRE)August 15, 2024 | americanbankingnews.comCritical Survey: Fortrea (NASDAQ:FTRE) vs. Aclarion (NASDAQ:ACON)August 14, 2024 | americanbankingnews.comFortrea (NASDAQ:FTRE) Hits New 1-Year Low Following Weak EarningsAugust 14, 2024 | americanbankingnews.comFortrea (NASDAQ:FTRE) Price Target Cut to $30.00August 14, 2024 | americanbankingnews.comFortrea (NASDAQ:FTRE) Given New $28.00 Price Target at Robert W. BairdAugust 14, 2024 | americanbankingnews.comFortrea (NASDAQ:FTRE) Given New $21.00 Price Target at BarclaysAugust 14, 2024 | markets.businessinsider.comFortrea Holdings Inc.: Hold Rating Affirmed Amidst Reduced Earnings Projections and Cautious OutlookAugust 14, 2024 | msn.comFortrea Holdings Inc. (NASDAQ:FTRE) Q2 2024 Earnings Call TranscriptAugust 12, 2024 | seekingalpha.comFortrea Holdings: Continued TroublesSee More Headlines Receive FTRE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fortrea and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/12/2024Today8/24/2024Next Earnings (Estimated)11/11/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryHealthcare Current SymbolNASDAQ:FTRE CUSIPN/A CIK1965040 Webwww.fortrea.com Phone877-495-0816FaxN/AEmployees18,000Year FoundedN/APrice Target and Rating Average Stock Price Target$27.20 High Stock Price Target$44.00 Low Stock Price Target$21.00 Potential Upside/Downside+23.5%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage12 Analysts Profitability EPS (Most Recent Fiscal Year)($1.39) Trailing P/E RatioN/A Forward P/E Ratio30.60 P/E Growth2.88Net Income$-3,400,000.00 Net Margins-4.11% Pretax Margin-2.80% Return on Equity4.76% Return on Assets1.87% Debt Debt-to-Equity Ratio0.98 Current Ratio1.47 Quick Ratio1.47 Sales & Book Value Annual Sales$3.01 billion Price / Sales0.65 Cash Flow$1.97 per share Price / Cash Flow11.19 Book Value$19.58 per share Price / Book1.13Miscellaneous Outstanding Shares89,400,000Free Float89,293,000Market Cap$1.97 billion OptionableOptionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Thomas H. Pike (Age 65)CEO, President & Chairman Comp: $2.19MMs. Jill McConnell (Age 49)Chief Financial Officer Comp: $735.39kMr. Mark A. Morais (Age 47)COO & President of Clinical Services Comp: $732.47kAmanda M. WarrenChief Accounting OfficerMs. Hima B. InguvaHead of Investor Relations & Corporate DevelopmentStillman HansonGeneral Counsel & Corporate SecretaryDr. John J. DoylePresident of ConsultingMore ExecutivesKey CompetitorsPACS GroupNYSE:PACSOption Care HealthNASDAQ:OPCHSotera HealthNASDAQ:SHCSurgery PartnersNASDAQ:SGRYHims & Hers HealthNYSE:HIMSView All CompetitorsInsiders & InstitutionsTruist Financial CorpSold 74,014 shares on 8/21/2024Ownership: 0.264%Brandes Investment Partners LPBought 519,344 shares on 8/19/2024Ownership: 2.727%Clearline Capital LPBought 190,728 shares on 8/16/2024Ownership: 0.279%William B. Walkup & Associates Inc.Bought 9,386 shares on 8/16/2024Ownership: 0.010%Algert Global LLCBought 8,552 shares on 8/16/2024Ownership: 0.010%View All Insider TransactionsView All Institutional Transactions FTRE Stock Analysis - Frequently Asked Questions How have FTRE shares performed this year? Fortrea's stock was trading at $34.90 at the start of the year. Since then, FTRE shares have decreased by 36.9% and is now trading at $22.03. View the best growth stocks for 2024 here. How were Fortrea's earnings last quarter? Fortrea Holdings Inc. (NASDAQ:FTRE) announced its quarterly earnings data on Monday, August, 12th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.07 by $0.10. Fortrea's quarterly revenue was down 8.6% on a year-over-year basis. Who are Fortrea's major shareholders? Fortrea's top institutional investors include Sessa Capital IM L.P. (7.55%), Baupost Group LLC MA (3.51%), Victory Capital Management Inc. (2.76%) and Brandes Investment Partners LP (2.73%). Insiders that own company stock include Thomas Pike and Peter M Neupert. View institutional ownership trends. How do I buy shares of Fortrea? Shares of FTRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:FTRE) was last updated on 8/24/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredThis Crypto Is Set to Explode in AugustThe Bitcoin Halving ignited the 2024 boom, and altcoins are primed to SKYROCKET. Last year we tipped off ou...Crypto 101 Media | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYou’ve been lied to for 615 days, and countingAll of the hype around artificial intelligence has been nothing but an artificial illusion…Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortrea Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortrea With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
